MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.vaccine.2022.05.071

Медицинская библиотека · Vaccine · 2022

Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.

Casagrande Thays Zanon, Costa-Rocha Ismael Artur da, Gavi Maria Bernadete Renoldi de Oliveira, Miyamoto Samira Tatiyama, Martins Priscila Costa, Serrano Érica Vieira, Dinis Valquiria Garcia, Machado Ketty Lysie Libardi Lira, Gouvea Sonia Alves, Caser Larissa Carvalho, Campi-Azevedo Ana Carolina, Teixeira-Carvalho Andréa, Peruhype-Magalhães Vanessa, Bissoli Maria de Fatima, Gouvea Maria da Penha Gomes, Lima Sheila Maria Barbosa de, Miranda Emily Hime, Trindade Gisela Freitas, Lyra Danielle Grillo Pacheco, Burian Ana Paula Neves, Neto Lauro Ferreira da Silva Pinto, da Mota Licia Maria Henrique, Martins-Filho Olindo Assis, Valim Valéria

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Yellow fever (YF) vaccination is known to induce a suboptimal response in patients with autoimmune diseases (AIDs). To date, few studies have focused on the performance of 17DD-YF vaccination in patients with spondyloarthritis (SpA). In general, patients with SpA are young and have less comorbidities than other patients with AIDs, and frequently receive biological disease-modifying antirheumatic drugs (DMARDs) that may impact their response to vaccines. Taking this background information, the present study aimed to investigate whether the use of biological DMARDs, even after planned washout, or disease activity measured by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), would impact the overall performance of planned 17DD-YF primary vaccination in patients with SpA. For this purpose, 74 subjects were enrolled in a prospective study, including adult patients with SpA (SpA; n = 51) and a healthy control (HC; n = 23) group. Analysis of YF specific neutralizing antibodies test (PRNT), along with YF viremia and the levels of serum chemokines, cytokines, and growth factors were performed at distinct time points (D0, D3, D4, D5, D6, D7, D14, and D28). The BASDAI scores were evaluated at D0 and D180. Data demonstrated that overall, the SpA group presented lower PRNT titers and seropositivity rates as compared to the HC group (GeoMean = 112 vs. 440; 73% vs. 96%, respectively). In SpA subgroup analyses, previous biological DMARDs (BIO-IT) led to a lower PRNT titers (BIO-IT 79, 95% CI [39-150] vs. without biological DMARDs [non-BIO-IT] 159, 95% CI [94-267], p < 0.001). The non-BIO-IT group achieved a response similar to the HC group (81% vs. 96%, p = 0.112), whereas the BIO-IT group had a lower seroconversion rate (64% vs. 96% HC, p = 0.007). The BASDAI was not associated with PRNT levels and did not change after 6 months of follow-up. No differences in YF viremia were observed amongst subgroups. Higher baseline levels of serum biomarkers were observed in the BIO-IT group vs. the non-BIO-IT group, as well as in those with a BASDAI ≥ 4 vs. those with a BASDAI < 4. Increasing levels of several biomarkers were observed in SpA, especially in the BIO-IT and BASDAI ≥ 4 subgroups throughout the timeline kinetics, with impairment/disturbance in the IFN-γ/IL-10 axis around the peak of viremia (D5). Altogether, these findings suggested that the use of biological DMARDs impacts the response to the 17DD-YF vaccine, even after planned washout. Therefore, previous biological DMARD therapy, the inflammatory status prior vaccination, and impairment of the IFN-γ/IL-10 axis at the peak of viremia may determine the immunogenicity of 17DD-YF vaccination in patients with SpA.

Для цитирования: Casagrande Thays Zanon, Costa-Rocha Ismael Artur da, Gavi Maria Bernadete Renoldi de Oliveira, Miyamoto Samira Tatiyama, Martins Priscila Costa, Serrano Érica Vieira, Dinis Valquiria Garcia, Machado Ketty Lysie Libardi Lira, Gouvea Sonia Alves, Caser Larissa Carvalho, Campi-Azevedo Ana Carolina, Teixeira-Carvalho Andréa, Peruhype-Magalhães Vanessa, Bissoli Maria de Fatima, Gouvea Maria da Penha Gomes, Lima Sheila Maria Barbosa de, Miranda Emily Hime, Trindade Gisela Freitas, Lyra Danielle Grillo Pacheco, Burian Ana Paula Neves, Neto Lauro Ferreira da Silva Pinto, da Mota Licia Maria Henrique, Martins-Filho Olindo Assis, Valim Valéria. Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.. Vaccine. 2022. DOI: 10.1016/j.vaccine.2022.05.071.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.